Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The Hemostatic Agents Market?

The market for hemostatic agents has experienced vigorous expansion in the recent past. It is expected to escalate from a value of $4.19 billion in 2024 to $4.42 billion in 2025, with a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this growth during the historic period include an aging worldwide population, an increase in trauma and accident incidents, a higher prevalence of cardiovascular diseases, a rising occurrence of bleeding disorders, like hemophilia, and an increased patient count for liver diseases and coagulation defects.

Over the coming years, the hemostatic agents market is anticipated to experience substantial growth. A compound annual growth rate (CAGR) of 5.3% is predicted to increase the market to $5.43 billion by 2029. The growth during this forecast period can be attributed to the rise in surgical procedures, growth of minimally invasive surgeries, increased demand for orthopedic surgeries as well as aesthetic and cosmetic surgeries, and the growing necessity for hemostasis in dental surgeries. Key trends for this period include advancements in the formulations of hemostatic agents, introduction of bioengineered and recombinant agents, improvement in product shelf-life and stability, development of combination products, and the creation of synthetic and absorbable hemostats.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25780&type=smp

What Are The Primary Factors Supporting The Hemostatic Agents Market Expansion?

The predicted growth of the hemostatic agents market is directly tied to the rising number of surgical procedures. Healthcare professionals carry out surgical operations using specialized equipment to either treat, repair, or remove parts of the body for medical reasons. The need for more surgeries mainly stems from a growing prevalence of chronic conditions, which usually necessitate surgical interference to manage patient health and improve their recovery outcome. Hemostatic agents play a crucial role in surgeries since they aid in stopping blood flow instantly, thus reducing blood loss and increasing visibility, making surgical procedures more accurate. For instance, the British Association of Aesthetic Plastic Surgeons (BAAPS) reported a massive increase of 102% in the number of cosmetic surgeries conducted in 2022 compared to 2021, reaching a total of 31,057 procedures performed in that year alone. Notably, 93% of these procedures were carried out on women, marking a 101% increase since 2021. Hence, the rise in surgical procedures is a significant driver for the expanding hemostatic agents market.

Which Segments Define The Structure Of The Hemostatic Agents Market?

The hemostatic agents market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Fibrin Sealants, Other Types

2) By Application: Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Other Applications

3) By End-User: Hospitals, Surgery Centers, Nursing Homes, Other End Users

Subsegments:

1) By Thrombin-Based Hemostats: Bovine Thrombin, Human Thrombin, Poxidized Regenerated Cellulose (Orc)Ine Thrombin, Combined Thrombin Products

2) By Gelatin-Based Hemostats: Absorbable Gelatin Sponges, Gelatin Powder, Gelatin Paste, Gelatin With Thrombin

3) By Collagen-Based Hemostats: Collagen Sponges, Collagen Powder, Collagen With Thrombin, Collagen Sheets Or Patches

4) By Oxidized Regenerated Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Pads, Oxidized Regenerated Cellulose (ORC) Mesh, Oxidized Regenerated Cellulose (ORC) Powder, Oxidized Regenerated Cellulose (ORC) With Other Active Agents

5) By Combination Hemostats: Gelatin And Thrombin Combinations, Collagen And Thrombin Combinations, Oxidized Regenerated Cellulose (ORC) And Thrombin Combinations, Multi-Agent Combinations

6) By Fibrin Sealants: Human Plasma-Derived Fibrin Sealants, Recombinant Fibrin Sealants, Sprayable Fibrin Sealants, Liquid Fibrin Sealants, Fibrin Sealants With Antimicrobials

7) By Other Types: Polysaccharide-Based Hemostats, Synthetic Polymer-Based Hemostats, Microfibrillar Collagen Hemostats, Chitosan-Based Hemostats, Calcium-Based Hemostats

What Strategic Shifts And Innovations Are Influencing The Hemostatic Agents Market?

Leading organizations in the hemostatic agents market are concentrating on producing innovative solutions, like collagen-based hemostats, to deliver swift and efficient hemostasis and tissue sealing for both extensive and minimally invasive surgery. Collagen-based hemostats are types of hemostatic materials made from refined collagen, which aid in halting bleeding by amplifying the body’s inherent clotting procedure at the wound or surgical cut point. For example, in March 2025, Baxter, a healthcare firm based in the US, unveiled HEMOPATCH Sealing Hemostat, an absorbable pad made of collagen. This enhanced collagen pad features a dual-action setup merging a collagen matrix with an NHS-PEG layer, which transforms into a hydrogel when it comes into contact with moisture, thereby promptly sealing bleeding zones. It strongly adheres to damp tissues, making it ideal for both extensive and minimally invasive surgeries, where other agents might not be as useful. The patch accomplishes hemostasis in under two minutes and does not require temperature-regulated storage or unique preparation, making surgical operations more efficient. Furthermore, it naturally disintegrates in the human body within 6 to 8 weeks and can be preserved at room temperature for up to three years which cater to vital clinical and storage needs.

Who Are The Primary Market Leaders In The Hemostatic Agents Market?

Major companies operating in the hemostatic agents market are Pfizer Inc., Johnson & Johnson Services Inc., Becton, Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z-Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., Biom’Up SAS.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/hemostatic-agents-global-market-report

What Regional Factors Are Accelerating Growth In The Hemostatic Agents Market?

North America was the largest region in the hemostatic agents market in 2024. The regions covered in the hemostatic agents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25780&type=smp

Browse Through More Reports Similar to the Global Hemostatic Agents Market 2025, By The Business Research Company

Hemostasis Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Hepatitis Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report

Absorbable Hemostats Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model